A. Prasse (Freiburg, Germany), T. Maher (London, United Kingdom)
Investigation of the citrullination pathway in the pathogenesis of fibrotic lung disorders
K. Antoniou, K. Samara, I. Lasithiotaki, P. Pantelidis, N. Siafakas, A. Wells (Heraklion, Greece; London, United Kingdom)
|   |
Small moleculae ACE2 activator, diminazene aceturate attenuates bleomycin-induced pulmonary fibrosis
V. Shenoy, Y. Qi, D. Gupta, M. Katovich, M. Raizada (Gainesville, United States Of America)
| |
KL-6 is a useful serum biomarker for early detection of interstitial lung disease
N. Kohno, N. Ishikawa, N. Deguchi, H. Iwamoto, S. Ohshimo, K. Fujitaka, Y. Haruta, H. Murai, N. Hattori (Hiroshima, Japan)
| |
ProSP-B as a possible biomarker in idiopathic interstitial pneumonias (ILD)
M. Kreuter, A.K. Rossler, N. Kahn, K. Hornemann, T. Muley, F. Herth (Heidelberg, Germany)
| |
Serum SP-A as predictor of disease progression in patients with pulmonary alveolar proteinosis
F. Bonella, X. He, S. Ohshimo, J. Guzman, U. Costabel (Essen, Bochum, Germany; Hiroshima, Japan)
| |
Thrombin induces epithelial-mesenchymal transition via PAR1, PKC and ERK1/2 pathways in A549 cells
J.S. Song, C.M. Kang, C.K. Park, H.K. Yoon (Seoul, Republic Of Korea)
| |
Inhibitory effect of statins on fibrogenic mediator production from lung cells
H. Oka, H. Ishii, K. Komiya, H. Kushima, J. I. Kadota (Oita, Japan)
| |
Interdependence of endothelin-1 and transforming growth factor-β1 on Wnt3a expression in idiopathic pulmonary fibrosis
J. Zhong, M. Roth, M. Tamm, D. Lardinois, K. Hostettler (Basel, Switzerland)
| |
Occupational and environmental impact on the clinical course of autoimmune pulmonary alveolar proteinosis
Y. Inoue, K. Nakata, T. Arai, E. Yamaguchi, T. Ichiwata, M. Ebina, R. Tazawa, H. Ishii, Y. Setoguchi, M. Kitaichi, M. Akira, K. Tatsumi, Y. Nasuhara, K. Cho, Y. Tsuchihashi, K. Uchida, T. Takada, H. Nakayama, K. Tomii, C. Sugimoto, Y. Kohashi, S. Ohkouchi, Y. Kasahara, K. Morimoto, N. Sakamoto (Osaka, Niigata, Nagoya, Tokyo, Sendai, Chiba, Hokkaido, Nagasaki, Kobe, Japan)
| |
Adipose stem cell therapy in mice on repetitive intratracheal bleomycin induced pulmonary fibrosis
S.H. Lee, E.J. Lee, S.H. Lee, G.Y. Hur, S.Y. Lee, S.Y. Lee, J.H. Kim, J.J. Shim, C. Shin, K.H. In, K.H. Kang, C.S. Uhm, H.K. Kim, K.S. Yang, S. Park, H.S. Kim, Y.M. Kim (Seoul, Seongnam-si, Republic Of Korea)
| |
Diffuse alveolar hemorrhage caused by primary antiphospholipid syndrome
R. Cartin-Ceba, T. Peikert, A. Ashrani, K. Keogh, S. Ytterberg, U. Specks (Rochester, United States Of America)
| |
Lung-limited IgG4-related disease: A new form of IgG4-related disease?
Y. Waseda, S. Matsui, H. Yamamoto, T. Ogura, A. Hebisawa, F. Sakai, Y. Terasaki, Y. Kurihara, K. Chida, Y. Yatagai, F. Fukushima, M. Kuba, K. Miyashita, M. Toyoshima, M. Ishida, H. Hayashi, Y. Tsuchiya, K. Ohishi, Y. Morio, K. Konishi, M. Fujimura (Kanazawa, Matsumoto, Yokohama, Kiyose, Saitama, Bunkyoku, Kawasaki, Hamamatsu, Nakagun, Shimotsugagun, Minowan, Fukui, Nagasaki, Ube, Japan)
| |
Prolonged sirolimus therapy in advanced pulmonary lymphangioleiomyomatosis; a multicenter French experience
C. Gomez, C. Taillé, R. Lazor, B. Crestani, V. Cottin, M. Reynaud-Gaubert (Marseille, Paris, Lyon, France)
| |
A retrospective clinical and radiological review of 20 Castleman‘s disease cases
Y. Ichimura, J. Terada, Y. Naito, T. Fujita, T. Urushibara, A. Shigeta, T. Sakurai, K. Iesato, F. Kuroda, Y. Tada, S. Sakao, K. Kurosu, Y. Kasahara, N. Tanabe, Y. Takiguchi, K. Terada (Chiba, Japan)
| |
MUSIC: Efficacy and safety of macitentan in idiopathic pulmonary fibrosis (IPF)
J. Behr, R. Million-Rousseau, A. Morganti, L. Perchenet, G. Raghu (Bochum, Germany; Allschwil, Switzerland; Seattle, United States Of America)
| |
Efficacy of rituximab in patients with connective tissue disease associated interstitial lung disease: Preliminary results in safety and clinical response
J. Gómez-Seco, M.J. Rodríguez-Nieto, F. Romero-Bueno, S. Recuero-Díaz, T. Presa-Abos, O. Sánchez-Pernaute, F. Villar-Álvarez, I. Fernández-Ormaechea (Madrid, Spain)
| |
The death receptors (DRs) expressed on alveolar lymphocytes (AL) in interstitial lung diseases (ILD) participate in apoptosis regulation
A. Dyczek, B. Balicka-Slusarczyk, J. Szczeklik, G. Przybylsski, A. Jarzemska, K. Szablowska, T. Wandtke, P. Kopinski (Krakow, Bydgoszcz, Poland)
| |
Distinct clinical characteristics of idiopathic interstitial pneumonia predominant in upper lobes
T. Oda, E. Hagiwara, T. Baba, H. Kitamura, A. Nakazawa, T. Ogura (Yokohama, Japan)
| |